Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,880 | -56,385 | -82,667 | -14,859 | 4,134 |
| Depreciation Amortization | 5,729 | 10,583 | 76,407 | 14,487 | 21,382 |
| Income taxes - deferred | -7 | 260 | -6,327 | -5,270 | -1,766 |
| Accounts receivable | 408 | 3,366 | -1,305 | -5,630 | -6,216 |
| Accounts payable and accrued liabilities | 42 | -2,506 | -11 | 1,965 | -1,100 |
| Other Working Capital | -823 | -13,092 | -12,123 | -11,378 | -11,956 |
| Other Operating Activity | 16,719 | 63,177 | 24,238 | 25,094 | 3,919 |
| Operating Cash Flow | $11,188 | $5,403 | $-1,788 | $4,409 | $8,397 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,329 | N/A | N/A | N/A | 2,501 |
| PPE Investments | -6,226 | -7,734 | -5,427 | -7,486 | -5,143 |
| Net Acquisitions | 4,496 | -600 | N/A | N/A | -476 |
| Investing Cash Flow | $-401 | $-8,334 | $-5,427 | $-7,486 | $-3,118 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -284 | -201 |
| Common Stock Issued | N/A | 76 | 23 | 16 | 1,128 |
| Common Stock Repurchased | -9,485 | -10,914 | -5,000 | N/A | N/A |
| Other Financing Activity | -1,066 | -1,891 | -1,347 | -4,584 | -7,706 |
| Financing Cash Flow | $-10,551 | $-12,729 | $-6,324 | $-4,852 | $-6,779 |
| Exchange Rate Effect | 86 | -48 | 79 | -130 | 69 |
| Beginning Cash Position | 57,159 | 72,867 | 86,327 | 94,386 | 95,817 |
| End Cash Position | 57,481 | 57,159 | 72,867 | 86,327 | 94,386 |
| Net Cash Flow | $322 | $-15,708 | $-13,460 | $-8,059 | $-1,431 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,188 | 5,403 | -1,788 | 4,409 | 8,397 |
| Capital Expenditure | -6,826 | -7,734 | -5,427 | -7,486 | -5,143 |
| Free Cash Flow | 4,362 | -2,331 | -7,215 | -3,077 | 3,254 |